Reply to "generic competition"
Only about 20% of drugs in this area can be caught by UNS.
Revenue when off patent drops to 30-35% for pharma's.
UNS only get a % of that above the 30-35%.
So if the pharma retains 60% UNS get % of 25-30% revenue.
price in 2014=2015, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)